Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mark A. Meservey"'
Autor:
Steven L. Yoder, Carl L. Heifetz, Jeffrey W. Gage, Mark A. Meservey, Sara A. Wold, Michael A. Cohen, Gregory E. Roland, Gail B. Mailloux
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 18:41-47
Cefdinir (FK482), a new oral cephalosporin, displayed potent oral activity versus induced infections in mice. In studies using beta-lactamase-nonproducing (beta LAC-) and -producing (beta LAC+) Staphylococcus aureus strains, respective PD50s (in mg/k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45285becaac42dfd4f8494bda6c1c01c
https://doi.org/10.1016/0732-8893(94)90132-5
https://doi.org/10.1016/0732-8893(94)90132-5
Autor:
Michael A. Cohen, Mark A. Meservey, Martin A. Shapiro, Carl L. Heifetz, Josephine C. Sesnie, M D Huband, E.Themis Joannides, Gregory E. Roland
Publikováno v:
Diagnostic microbiology and infectious disease. 18(1)
Cefdinir (FK482), a new oral cephalosporin with enhanced beta-lactamase stability, was tested by microbroth dilution against respiratory, urogenital, and skin and skin-structure bacterial pathogens. Included were beta-lactamase (beta LAC)-producing a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c1d44a05562856c93f2ed9542bc7308
https://pubmed.ncbi.nlm.nih.gov/8026155
https://pubmed.ncbi.nlm.nih.gov/8026155
Autor:
Steven L. Yoder, John M. Domagala, M D Huband, M E Dazer, Michael A. Cohen, Mark A. Meservey, Gregory E. Roland
PD 138312 and PD 140248 are new quinolones with high in vitro activities against a wide spectrum of bacterial species, notably including gram-positive isolates. The respective MICs (in micrograms per milliliter) of PD 138312 and PD 140248 capable of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d128baf33ddf5a898789df650ad0732e
https://europepmc.org/articles/PMC192739/
https://europepmc.org/articles/PMC192739/
